Market Overview

Morgan Keegan Reiterates Outperform on Health Care REIT (HCN)


Morgan Keegan is out with a research report this morning, where it reiterates its Outperform rating on Health Care REIT (NYSE: HCN); it has a $52.00 price target on the stock, up from $51.00.

The MK analysts recently adjusted the earnings model for HCN, which modestly raise revenue projections, but have no impact on FFO and FAD. Their 2010 estimates remain $3.19 and $2.95, respectively. Their 2011 estimates remain
$3.35 and $3.08, respectively.

The analysts believe that management's goal of 5% NOI growth from its joint venture is reasonable. In its RIDEA joint venture with Merrill Gardens, the rents
Health Care REIT will forgo on the 13 facilities is contributing to the venture, and its acquisition pace.

Posted-In: Morgan KeeganAnalyst Color Price Target Analyst Ratings


Related Articles (HCN)

View Comments and Join the Discussion!

Latest Ratings

KEMB. Riley FBRDowngrades27.2
ROKGabelli & Co.Downgrades
SSRMB. Riley FBRUpgrades23.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Jefferies Reiterates Buy Rating on Susser Holdings (SUSS)

Not So Sunny In South Florida Real Estate Market